Emcure Pharmaceuticals Limited (EMCURE)
Business Responsibility and Sustainability Report for the Financial Year 2025-26
Business Responsibility and Sustainability Report FY 2025-26
- Emcure commits to sustainable growth, ethical governance, and stakeholder value.
- Achieved 8.5% reduction in Scope 2 GHG emissions; focus on renewable energy and water conservation.
- Zero fatalities maintained; strong EHS and workplace safety culture.
- 50.26% turnover from exports; 91% employees male, 9% female; 20% women on Board.
- TÜV Rheinland provided reasonable assurance on BRSR data and disclosures.
- Waste recycling increased; total waste generated 6,256 MT with 3,460 MT recycled.
- No fines or penalties; robust grievance redressal and anti-corruption policies in place.
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 EMCURE — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add EMCURE to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on Emcure Pharmaceuticals Limited
Important.
The summary above is generated automatically from Emcure Pharmaceuticals Limited's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.